InnovAtlasMalaria No More
Technology and manufacturing company

Rapigen / Rapigen America Inc.

DevelopDeliver

Rapigen develops and manufactures rapid diagnostic tests for malaria, including tests designed to improve detection of P. falciparum and P. vivax.

6
Endemic countries
1
U.S. states
5
Products and programs
About

What they do

Rapigen develops and manufactures rapid diagnostic tests for malaria, including tests designed to improve detection of P. falciparum and P. vivax.1 The malaria portfolio spans development and delivery stages.1 Its three 2nd-generation BIOCREDIT malaria RDTs are WHO prequalified, while its latest 3rd-generation cHL products combine HRPII and LDH detection and are undergoing clinical and field evaluation.1 Rapigen America has a U.S. office in Germantown, Maryland, and its headquarters and primary manufacturing operations are in South Korea.1

In the United States
Products and programs

In the field and in development

BIOCREDIT Malaria Ag Pf (pLDH)2,1

2nd-generation, WHO prequalified

BIOCREDIT Malaria Ag Pf (pLDH/HRPII)3,1

2nd-generation, WHO prequalified

BIOCREDIT Malaria Ag Pf/Pv (pLDH/pLDH)4,1

2nd-generation, WHO prequalified

BIOCREDIT Malaria Ag Pf (cHL)1

3rd-generation, clinical/field evaluation

BIOCREDIT Malaria Ag Pf/Pv (cHL/L)1

3rd-generation, clinical/field evaluation

Where they work

Partnerships in 6 endemic countries

Product testingResearchManufacturing and supply
Brazil
Latin America
  • CEPEM · clinical evaluation / WHO prequalification study1
Ethiopia
Africa
  • Jimma University · clinical evaluation / WHO prequalification study1
  • Ethiopian Pharmaceuticals Supply Service (EPSS) · national procurement5,1
Indonesia
Asia-Pacific
  • Eijkman Institute for Molecular Biology, Jakarta · clinical evaluation / WHO prequalification study6,1
  • Exeins Health Initiative (EHI) · analytical studies / WHO prequalification study1
Nigeria
Africa
  • Nigerian Institute of Medical Research, Lagos · clinical evaluation / WHO prequalification study7,1
Senegal
Africa
  • Institut Pasteur de Dakar · clinical evaluation / WHO prequalification study1
Sudan
Africa
  • Institute of Endemic Diseases, Khartoum · clinical evaluation / WHO prequalification study6,1
Sources

Where this comes from